Find News

Filter articles

Applied Filters

Showing 91 to 100 of 706 results

LSPN Europe 2018: Technology advancing at ‘incredible pace’ in life sciences

EU, US15-11-2018

The speed of technological advancements in the life sciences industry is forcing patent lawyers to consider whether the norms they’re used to dealing with in the profession still apply.

IBM patent targets blockchain in open scientific research


Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.

CRISPR Therapeutics expands MaxCyte partnership into immuno-oncology


Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena. 

UK life sciences bodies submit concerns over ‘no deal’ Brexit

EU, UK12-11-2018

Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets.

BMS company not required to pay damages in trade secrets case


A jury has said that Flexus Biosciences, a company owned by Bristol-Myers Squibb, does not need to pay damages despite being liable for trade secrets misappropriation.

Roche, Boehringer and AbbVie have strong pot portfolios: report

International, US09-11-2018

The strongest cannabidiol patent portfolios are owned by Roche, Boehringer Ingelheim, and AbbVie, according to a report released earlier this week.

EPO revokes Bayer broccoli patent


The European Patent Office has revoked a Bayer-owned patent which covers a type of broccoli adapted to make their harvesting easier. 

AbbVie and Momenta announce Humira patent licence agreement

EU, US08-11-2018

Biotech company Momenta has obtained the rights to use AbbVie’s Humira IP, enabling the global commercialisation of Momenta’s proposed Humira biosimilar, M923.

Womble adds McCarter patent attorney in Boston


Womble Bond Dickinson has strengthened its Boston-based life sciences team with the addition of patent attorney Briana Erickson.

Pfizer teams up with Nektar in oncology deal


Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company.

Showing 91 to 100 of 706 results